Swiss National Bank
NXTC icon

Swiss National Bank’s NextCure NXTC Stock Holding History

Swiss National Bank’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,300
Closed -$276K – 2650
2021
Q1 		$276K Hold
2,300
– – ﹤0.01% 2475
2020
Q4 		$301K Hold
2,300
– – ﹤0.01% 2485
2020
Q3 		$243K Hold
2,300
– – ﹤0.01% 2426
2020
Q2 		$592K Buy
+2,300
New +$876K ﹤0.01% 2339

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Swiss National Bank's NXTC Position: Q2 2021 in Review

Swiss National Bank sold out of NextCure (NXTC) in Q2 2021, closing a stake of 2,300 shares — an estimated $276K sold.

Swiss National Bank first reported a position in NXTC in Q2 2020 and held it in 4 quarters. The position peaked at $592K in Q2 2020. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Swiss National Bank reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Swiss National Bank sold 2,300 NextCure shares in Q2 2021, an estimated $276K.
  • Swiss National Bank first reported a position in NextCure in Q2 2020 and held it in 4 quarters.
  • Swiss National Bank's NextCure position peaked at $592K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.